Research and Development

Showing 15 posts of 9594 posts found.

takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer

July 27, 2018 Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma

Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
gsk_boronia_australia

GSK forges $300m partnership with 23andMe to boost preclinical R&D

July 26, 2018 Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma

In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
394px-ad_versus_co

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 26, 2018 Research and Development Alzheimer's disease, BAN2401, Biodgen, Eisai, phase 2, research

An experimental drug developed by the Massachusetts-based multinational Biogen and their Japanese partner Eisai has been shown to significantly slow …
Matt Hancock

NHS to stockpile drugs in preparation for no-deal Brexit

July 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …

FDA approves first endometriosis pain management drug in a decade

July 25, 2018 Research and Development, Sales and Marketing AbbVie, FDA, Neurocrine Biosciences, endometriosis, pharma

The FDA has confirmed its approval of AbbVie and Neurocrine Biosciences’ Orilissa (elagolix), a nonpeptide small molecule gonadotropin-releasing hormone (GnRH) …

HPV vaccine to be given to boys in England

July 25, 2018 Research and Development Cancer, HPV, infectious disease, sexually transmitted diseases, vaccines, virus

The government has announced that boys in England aged 12 and 13 will be vaccinated against Human Papilloma Virus (HPV) …

Pfizer to build $465m sterile injectable plant in Michigan

July 25, 2018 Manufacturing and Production, Research and Development Michigan, Pfizer, US, manufacturing, pharma

Pfizer has unveiled plans to invest $465 million to build a new sterile injectables plant in Portage, Michigan, saying that …

More antidepressants being prescribed to children in UK

July 25, 2018 Research and Development antidepressants, children, mental health, prescription, young people

Figures have revealed a trend towards an increased number of prescriptions for antidepressants for children in England, Scotland, and Northern …

Eleven babies dead after Dutch viagra trial

July 25, 2018 Research and Development Netherlands, clinical trial, deaths, premature, viagra

A trial of the drug sildenafil, commonly sold under the brand name Viagra, has been halted immediately after the death …
stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
celgene_building

Celgene’s Revlimid combo meets Phase 3 goal in relapsed/refractory indolent lymphoma

July 24, 2018 Manufacturing and Production, Research and Development Celgene, Revlimid, lymphoma, pharma

Celgene has lifted the curtain on new Phase 3 data for its combo of Revlimid (lenalidomide) plus rituximab (R2) in …
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …
The Gateway to Local Adoption Series

Latest content